vs

Side-by-side financial comparison of FRANKLIN STREET PROPERTIES CORP (FSP) and AVITA Medical, Inc. (RCEL). Click either name above to swap in a different company.

FRANKLIN STREET PROPERTIES CORP is the larger business by last-quarter revenue ($26.0M vs $17.6M, roughly 1.5× AVITA Medical, Inc.). FRANKLIN STREET PROPERTIES CORP runs the higher net margin — -28.1% vs -66.0%, a 37.8% gap on every dollar of revenue. On growth, AVITA Medical, Inc. posted the faster year-over-year revenue change (-4.3% vs -8.2%). AVITA Medical, Inc. produced more free cash flow last quarter ($-6.1M vs $-12.7M). Over the past eight quarters, AVITA Medical, Inc.'s revenue compounded faster (26.0% CAGR vs -8.7%).

Franklin Street Properties Corp is a Massachusetts-based real estate investment trust (REIT) in the United States. It primarily invests in, owns, and operates high-quality office properties across major U.S. metropolitan markets, serving corporate tenants across various industry segments, and delivers stable long-term returns via rental income and strategic asset management.

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East...

FSP vs RCEL — Head-to-Head

Bigger by revenue
FSP
FSP
1.5× larger
FSP
$26.0M
$17.6M
RCEL
Growing faster (revenue YoY)
RCEL
RCEL
+3.9% gap
RCEL
-4.3%
-8.2%
FSP
Higher net margin
FSP
FSP
37.8% more per $
FSP
-28.1%
-66.0%
RCEL
More free cash flow
RCEL
RCEL
$6.5M more FCF
RCEL
$-6.1M
$-12.7M
FSP
Faster 2-yr revenue CAGR
RCEL
RCEL
Annualised
RCEL
26.0%
-8.7%
FSP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FSP
FSP
RCEL
RCEL
Revenue
$26.0M
$17.6M
Net Profit
$-7.3M
$-11.6M
Gross Margin
59.4%
81.2%
Operating Margin
-27.9%
-59.1%
Net Margin
-28.1%
-66.0%
Revenue YoY
-8.2%
-4.3%
Net Profit YoY
14.1%
-0.3%
EPS (diluted)
$-0.06
$-0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FSP
FSP
RCEL
RCEL
Q4 25
$26.0M
$17.6M
Q3 25
$27.3M
$17.1M
Q2 25
$26.7M
$18.4M
Q1 25
$27.1M
$18.5M
Q4 24
$28.4M
$18.4M
Q3 24
$29.7M
$19.5M
Q2 24
$30.8M
$15.2M
Q1 24
$31.2M
$11.1M
Net Profit
FSP
FSP
RCEL
RCEL
Q4 25
$-7.3M
$-11.6M
Q3 25
$-8.3M
$-13.2M
Q2 25
$-7.9M
$-9.9M
Q1 25
$-21.4M
$-13.9M
Q4 24
$-8.5M
$-11.6M
Q3 24
$-15.6M
$-16.2M
Q2 24
$-21.0M
$-15.4M
Q1 24
$-7.6M
$-18.7M
Gross Margin
FSP
FSP
RCEL
RCEL
Q4 25
59.4%
81.2%
Q3 25
60.9%
81.3%
Q2 25
59.9%
81.2%
Q1 25
62.8%
84.7%
Q4 24
59.7%
87.6%
Q3 24
61.0%
83.7%
Q2 24
64.2%
86.1%
Q1 24
64.7%
86.4%
Operating Margin
FSP
FSP
RCEL
RCEL
Q4 25
-27.9%
-59.1%
Q3 25
-30.5%
-53.6%
Q2 25
-29.2%
-60.5%
Q1 25
-78.9%
-63.9%
Q4 24
-29.9%
-54.1%
Q3 24
-52.4%
-70.6%
Q2 24
-68.0%
-102.8%
Q1 24
-24.0%
-155.0%
Net Margin
FSP
FSP
RCEL
RCEL
Q4 25
-28.1%
-66.0%
Q3 25
-30.5%
-77.3%
Q2 25
-29.5%
-53.9%
Q1 25
-79.1%
-74.9%
Q4 24
-30.0%
-63.0%
Q3 24
-52.6%
-82.9%
Q2 24
-68.2%
-101.3%
Q1 24
-24.2%
-168.0%
EPS (diluted)
FSP
FSP
RCEL
RCEL
Q4 25
$-0.06
$-0.37
Q3 25
$-0.08
$-0.46
Q2 25
$-0.08
$-0.38
Q1 25
$-0.21
$-0.53
Q4 24
$-0.09
$-0.44
Q3 24
$-0.15
$-0.62
Q2 24
$-0.20
$-0.60
Q1 24
$-0.07
$-0.73

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FSP
FSP
RCEL
RCEL
Cash + ST InvestmentsLiquidity on hand
$30.6M
$18.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$607.0M
$-16.6M
Total Assets
$892.9M
$56.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FSP
FSP
RCEL
RCEL
Q4 25
$30.6M
$18.2M
Q3 25
$31.4M
$23.3M
Q2 25
$29.4M
$15.7M
Q1 25
$30.2M
$25.8M
Q4 24
$41.1M
$35.9M
Q3 24
$40.9M
$44.4M
Q2 24
$30.2M
$54.1M
Q1 24
$34.2M
$68.2M
Stockholders' Equity
FSP
FSP
RCEL
RCEL
Q4 25
$607.0M
$-16.6M
Q3 25
$615.3M
$-6.7M
Q2 25
$624.7M
$-12.9M
Q1 25
$633.4M
$-4.6M
Q4 24
$655.9M
$4.5M
Q3 24
$665.4M
$12.2M
Q2 24
$682.1M
$23.9M
Q1 24
$703.9M
$32.6M
Total Assets
FSP
FSP
RCEL
RCEL
Q4 25
$892.9M
$56.4M
Q3 25
$901.0M
$63.7M
Q2 25
$903.2M
$58.1M
Q1 25
$916.4M
$69.6M
Q4 24
$946.9M
$79.7M
Q3 24
$981.5M
$81.1M
Q2 24
$1.0B
$87.8M
Q1 24
$1.0B
$97.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FSP
FSP
RCEL
RCEL
Operating Cash FlowLast quarter
$3.8M
$-5.4M
Free Cash FlowOCF − Capex
$-12.7M
$-6.1M
FCF MarginFCF / Revenue
-48.6%
-34.7%
Capex IntensityCapex / Revenue
63.0%
3.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-25.3M
$-33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FSP
FSP
RCEL
RCEL
Q4 25
$3.8M
$-5.4M
Q3 25
$8.3M
$-5.2M
Q2 25
$-2.9M
$-10.2M
Q1 25
$-5.5M
$-10.3M
Q4 24
$9.0M
$-8.1M
Q3 24
$14.5M
$-7.2M
Q2 24
$-648.0K
$-12.8M
Q1 24
$-7.1M
$-20.9M
Free Cash Flow
FSP
FSP
RCEL
RCEL
Q4 25
$-12.7M
$-6.1M
Q3 25
$3.0M
$-6.2M
Q2 25
$-5.7M
$-10.8M
Q1 25
$-9.9M
$-10.5M
Q4 24
$-16.2M
$-9.7M
Q3 24
$8.6M
$-11.0M
Q2 24
$-5.1M
$-15.4M
Q1 24
$-15.8M
$-22.0M
FCF Margin
FSP
FSP
RCEL
RCEL
Q4 25
-48.6%
-34.7%
Q3 25
11.0%
-36.1%
Q2 25
-21.5%
-58.4%
Q1 25
-36.7%
-56.9%
Q4 24
-57.2%
-52.7%
Q3 24
29.1%
-56.1%
Q2 24
-16.7%
-101.6%
Q1 24
-50.8%
-198.2%
Capex Intensity
FSP
FSP
RCEL
RCEL
Q4 25
63.0%
3.8%
Q3 25
19.4%
5.5%
Q2 25
10.7%
2.8%
Q1 25
16.4%
1.2%
Q4 24
88.9%
8.8%
Q3 24
19.6%
19.2%
Q2 24
14.6%
17.5%
Q1 24
28.1%
10.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons